Post by peryannie4 on Oct 28, 2022 7:27:19 GMT -5
The combination medicine of Abacavir and Lamivudine is recommended by healthcare professionals to treat patients with human immunodeficiency virus type 1 (HIV-1) infection. This combination medicine is supplied as tablets in 300 mg and 600 mg to administer orally via the mouth. Healthcare professionals recommend administering Abacavir Lamivudine combination tablets orally, one tablet taken orally once a day, in combination with other antiretroviral agents, with or without food. One should screen for the HLA-B*5701 allele before initiating therapy with a combination medicine of Abacavir Lamivudine.